SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report, dated March 24, 2023, details a material definitive agreement and unregistered sales of equity securities by BioSig Technologies, Inc. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics and Transaction Details
The filing reports a private placement transaction (March PIPE) with the following specific metrics:
- Total Consideration Raised: $1,017,889.00
- Common Shares Sold: 935,130 shares at $1.0885 per share
- Warrants Issued to Investors: Warrants to purchase 467,565 shares at an exercise price of $1.026 per share
- Warrant Terms: Exercisable six months after issuance; expire five and one-half years after issuance
- Advisor Compensation: A warrant to purchase 49,465 shares issued to Laidlaw & Company (UK) Ltd. at an exercise price of $1.026 per share
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this is a transaction-specific report rather than a periodic financial statement.
Material Changes and Unusual Items
The primary material change is the entry into a Securities Purchase Agreement with accredited investors. The transaction was executed under Section 4(a)(2) and Regulation D (Rule 506) exemptions from registration. Additionally, the company entered into an engagement agreement with Laidlaw & Company (UK) Ltd. on February 24, 2023, resulting in the issuance of the Laidlaw Warrant as partial compensation.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard representations and warranties typical for such transactions. The transaction relies on specific exemptions from the Securities Act of 1933.
Key Facts for Investor Verification
- Verify the dilution impact of 935,130 new shares and 517,030 total warrant shares (investor and advisor combined) on existing shareholders.
- Confirm the exercise price of $1.026 per share relative to the current market price of BSGM stock.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and restrictions.
- Check the company's cash position post-transaction to assess runway, as the filing does not disclose pre-transaction liquidity.